PAR
Click for more information
2.42% 30.3¢ paradigm biopharmaceuticals limited..

Chart, page-2136

  1. twincreeks
    2,952 Posts.
    lightbulb Created with Sketch. 624
    clock Created with Sketch.
    30/07/21
    08:35
    Post #: 54889590
    yep pre-appoval - price we were comfortable at prior to approval last time.....fair value for P3 I would think should be above previous highs given the Bene agreement,
    PAR Price at posting: $2.22 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
MEU Marmota hopes to punch through the ceiling of a high-grade system at Goolagong – geology willing
right-arrow Created with Sketch.
NEWS AI stocks: What to expect in 2024-25
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
RIO Rio registers 2% drop in iron ore production in 2nd quarter of 2024
right-arrow Created with Sketch.
M2R Miramar sniffs 5.48% Cu, 54.4% Pb and 73.48g/t Ag at new WA prospect
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.3¢ 		Change
-0.008(2.42%) 		Mkt cap ! $105.8M
Open High Low Value Volume
30.5¢ 30.5¢ 30.0¢ $15.8K 52.08K

Buyers (Bids)

No. Vol. Price($)
9 141874 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 10606 9
View Market Depth
Last trade - 13.51pm 19/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.